Evaluation of FASN inhibitors by a versatile toolkit reveals differences in pharmacology between human and rodent FASN preparations and in antiproliferative efficacy in vitro vs. in situ in human cancer cells
2020 ◽
Vol 149
◽
pp. 105321
◽
Keyword(s):
Keyword(s):
Keyword(s):
2006 ◽
Vol 54
(12)
◽
pp. 4482-4492
◽
Keyword(s):
1986 ◽
Vol 76
(4)
◽
pp. 629-639
◽
Keyword(s):
Keyword(s):
Keyword(s):